يعرض 1 - 10 نتائج من 223 نتيجة بحث عن '"Jackson, Aimee"', وقت الاستعلام: 0.80s تنقيح النتائج
  1. 1
    رسالة جامعية
  2. 2
    دورية أكاديمية

    المساهمون: Fang, Zijian, Corbizi Fattori, Giuditta, McKerrell, Thoma, Boucher, Rebecca H, Jackson, Aimee, Fletcher, Rachel S, Forte, Dorian, Martin, Jose-Ezequiel, Fox, Sonia, Roberts, Jame, Glover, Rachel, Harris, Erica, Bridges, Hannah R, Grassi, Luigi, Rodriguez-Meira, Alba, Mead, Adam J, Knapper, Steven, Ewing, Joanne, Butt, Nauman M, Jain, Manish, Francis, Sebastian, Clark, Fiona J, Coppell, Jason, McMullin, Mary F, Wadelin, France, Narayanan, Srinivasan, Milojkovic, Dragana, Drummond, Mark W, Sekhar, Mallika, ElDaly, Hesham, Hirst, Judy, Paramor, Maike, Baxter, E Joanna, Godfrey, Anna L, Harrison, Claire N, Méndez-Ferrer, Simón

    مصطلحات موضوعية: myeloproliferative neoplasms, tamoxifen

    وصف الملف: ELETTRONICO

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/38001082; info:eu-repo/semantics/altIdentifier/wos/WOS:001109212900001; volume:14; issue:1; firstpage:1; lastpage:21; numberofpages:21; journal:NATURE COMMUNICATIONS; https://hdl.handle.net/11585/961528Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85177778608; https://www.nature.com/articles/s41467-023-43175-5Test

  3. 3
    دورية أكاديمية

    وصف الملف: application/pdf

    العلاقة: https://orca.cardiff.ac.uk/id/eprint/166940/1/Posttransplant%20MRD%20and%20T-cell%20chimerism%20status%20predict%20outcomes%20in.pdfTest; Loke, Justin, McCarthy, Nicholas, Jackson, Aimee, Siddique, Shamyla, Hodgkinson, Andrea, Mason, John, Crawley, Charles, Gilleece, Maria, Peniket, Andrew, Protheroe, Rachel, Salim, Rahuman, Tholouli, Eleni, Wilson, Keith https://orca.cardiff.ac.uk/view/cardiffauthors/A016108B.htmlTest, Andrew, Georgia, Dillon, Richard, Khan, Naeem, Potter, Victoria, Krishnamurthy, Pramila, Craddock, Charles and Freeman, Sylvie 2023. Posttransplant MRD and T-cell chimerism status predict outcomes in patients who received allografts for AML/MDS. Blood Advances 7 (14) , pp. 3666-3676. 10.1182/bloodadvances.2022009493 https://doi.org/10.1182/bloodadvances.2022009493Test file https://orca.cardiff.ac.uk/id/eprint/166940/1/Posttransplant%20MRD%20and%20T-cell%20chimerism%20status%20predict%20outcomes%20in.pdfTest

  4. 4
    دورية أكاديمية

    وصف الملف: application/pdf

    العلاقة: https://orca.cardiff.ac.uk/id/eprint/159487/1/KNAPPER,%20STEVE%20-%20Ruxolitinib%20Versus%20Best%20Available%20Therapy%20for%20Polycythemia.pdfTest; Harrison, Claire N., Nangalia, Jyoti, Boucher, Rebecca, Jackson, Aimee, Yap, Christina, O'Sullivan, Jennifer, Fox, Sonia, Ailts, Isaak, Dueck, Amylou C., Geyer, Holly L., Mesa, Ruben A., Dunn, William G., Nadezhdin, Eugene, Curto-Garcia, Natalia, Green, Anna, Wilkins, Bridget, Coppell, Jason, Laurie, John, Garg, Mamta, Ewing, Joanne, Knapper, Steven https://orca.cardiff.ac.uk/view/cardiffauthors/A016111L.htmlTest orcid:0000-0002-6405-4441 orcid:0000-0002-6405-4441, Crowe, Josephine, Chen, Frederick, Koutsavlis, Ioannis, Godfrey, Anna, Arami, Siamak, Drummond, Mark, Byrne, Jennifer, Clark, Fiona, Mead-Harvey, Carolyn, Baxter, Elizabeth Joanna, McMullin, Mary Frances and Mead, Adam J. 2023. Ruxolitinib versus best available therapy for polycythemia vera intolerant or resistant to hydroxycarbamide in a randomized trial. Journal of Clinical Oncology 41 (19) , pp. 3534-3544. 10.1200/JCO.22.01935 https://doi.org/10.1200/JCO.22.01935Test file https://orca.cardiff.ac.uk/id/eprint/159487/1/KNAPPER,%20STEVE%20-%20Ruxolitinib%20Versus%20Best%20Available%20Therapy%20for%20Polycythemia.pdfTest

  5. 5
  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية

    وصف الملف: application/pdf

    العلاقة: https://orca.cardiff.ac.uk/id/eprint/154302/1/12885_2022_Article_10221.pdfTest; Dillon, Richard, Maycock, Shanna, Jackson, Aimee, Fox, Sonia, Freeman, Sylvie, Craddock, Charles, Thomas, Catherine, Homer, Emma, Leahy, Jane, Mamwell, Anna, Potter, Nicola, Russell, Nigel, Wei, Andrew, Ommen, Hans Beier, Hemmaway, Claire, Knapper, Steve https://orca.cardiff.ac.uk/view/cardiffauthors/A016111L.htmlTest orcid:0000-0002-6405-4441 orcid:0000-0002-6405-4441 and Billingham, Lucinda 2022. Venetoclax combined with low dose cytarabine compared to standard of care intensive chemotherapy for the treatment of favourable risk adult acute myeloid leukaemia (VICTOR): Study protocol for an international, open-label, multicentre, molecularly-guided randomised, phase II trial. BMC Cancer 22 , 1174. 10.1186/s12885-022-10221-2 https://doi.org/10.1186/s12885-022-10221-2Test file https://orca.cardiff.ac.uk/id/eprint/154302/1/12885_2022_Article_10221.pdfTest

  8. 8
    دورية أكاديمية

    وصف الملف: text

    العلاقة: http://eprints.gla.ac.uk/251148/1/251148.pdfTest; Loke, J. et al. (2022) Combination romidepsin and azacitidine therapy is well tolerated and clinically active in adults with high‐risk acute myeloid leukaemia ineligible for intensive chemotherapy. British Journal of Haematology , 196(2), pp. 368-373. (doi:10.1111/bjh.17823 ) (PMID:34490623)

  9. 9
    دورية أكاديمية
  10. 10
    دورية أكاديمية